Zelira Therapeutics Limited
ZLDAF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$3,628 | -$36,569 | -$5,573 | -$11,945 |
| Dep. & Amort. | $270 | $0 | $545 | $589 |
| Deferred Tax | $0 | $0 | -$632 | -$4,554 |
| Stock-Based Comp. | -$1,187 | $0 | $405 | $2,692 |
| Change in WC | $0 | $1,731 | $863 | -$685 |
| Other Non-Cash | -$362 | $30,450 | -$2,857 | $4,478 |
| Operating Cash Flow | -$4,907 | -$4,389 | -$7,249 | -$9,427 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $736 | $0 |
| Other Inv. Act. | $1,153 | $920 | $2,093 | -$208 |
| Investing Cash Flow | $1,153 | $920 | $2,829 | -$208 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $2,098 | $3,924 | $0 | $0 |
| Stock Issued | $0 | $0 | $1,770 | $7,100 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1,092 | $0 | $0 | $0 |
| Financing Cash Flow | $3,190 | $3,924 | $1,770 | $7,100 |
| Forex Effect | -$16 | $146 | $50 | $311 |
| Net Chg. in Cash | -$580 | $601 | -$2,600 | -$2,225 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $586 | -$15 | $2,746 | $4,971 |
| End Cash | $6 | $586 | $146 | $2,746 |
| Free Cash Flow | -$4,907 | -$4,389 | -$7,249 | -$9,427 |